Answers are grounded in this paper and cite their sources.
The Cochrane tool has become the standard approach to assess risk of bias in randomized clinical trials but is frequently implemented in a non-recommended way. Based on published comments and how it is applied in practice in systematic reviews, the tool may be further improved by a revised structure and more focused guidance.
No takes yet. Share an insight, caveat, or question.
Jørgensen et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: